학술지 발간
No. | Author | Title | Journal Name | Year/Month |
---|---|---|---|---|
1355 | Jiamsiri S, Rhee C, Ahn HS, Poudyal N, Seo HW, Klinsupa W, Nilyanimit P, Premsri N, Namwat C, Vonpunsawad S, Chon Y, Park S, Kim DR, Unger ER, Markowitz L, Poovorawan Y, Rerks-Ngarm S, Excler JL, Lynch J | A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX(R)) in female school students in Thailand. | PLoS One | 05/2022 |
1354 | Kim JH | Managing Safe, Equitable, and Effective COVID-19 Vaccination. | Development Asia | 03/2022 |
1353 | Lewitus E, Sanders-Buell E, Bose M, O'Sullivan AM, Poltavee K, Li Y, Bai H, Mdluli T, Donofrio G, Slike B, Zhao H, Wong K, Chen L, Miller S, Lee J, Ahani B, Lepore S, Muhammad S, Grande R, Tran U, Dussupt V, Mendez-Rivera L, Nitayaphan S, Kaewkungwal J, Pitisuttithum P, Rerks-Ngarm S, O'Connell RJ, Janes H, Gilbert PB, Gramzinski R, Vasan S, Robb ML, Michael NL, Krebs SJ, Herbeck JT, Edlefsen PT, Mullins JI, Kim JH, Tovanabutra S, Rolland M | RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection. | Virus Evol | 03/2022 |
1352 | Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members | Operation Warp Speed: implications for global vaccine security. | Lancet Glob Health | 03/2022 |
1351 | Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members | Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics. | Lancet | 03/2022 |
1350 | Panzner U, Excler JL, Kim JH, Marks F, Carter D, Siddiqui AA | Recent Advances and Methodological Considerations on Vaccine Candidates for Human Schistosomiasis. | Front Trop Dis | 03/2022 |
1349 | Kim JH, McCann C | The emergence of a South-South and Triangular Cooperation approach to vaccine development. | J Glob Health Sci | 03/2022 |
1348 | Park SM, Gu MJ, Ju YJ, Cheon IS, Hwang KJ, Gill B, Shim BS, Jeong HJ, Son YM, Choi S, Jeung W, Han SH, Chu H, Yun CH | Intranasal Vaccination with Outer-Membrane Protein of Orientia tsutsugamushi induces Protective Immunity Against Scrub Typhus. | Immune Netw | 03/2022 |
1347 | Ali M, Qadri F, Kim DR, Islam MT, Im J, Ahmmed F, Khan AI, Zaman K, Marks F, Kim JH, Clemens JD | Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial. | Lancet Infect Dis | 03/2022 |
1346 | Alexander N, Carabali M, Lim JK | Estimating force of infection from serologic surveys with imperfect tests. | PLoS One | 03/2022 |
1345 | Fu H, Abbas K, Klepac P, van Zandvoort K, Tanvir H, Portnoy A, Jit M | Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries. | BMC Med | 03/2022 |
1344 | Mogasale VV, Saldanha P, Pai V, Rekha PD, Mogasale V | A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India. | Sci Rep | 03/2022 |
1343 | Mogasale V, Ngogoyo SM, Mogasale VV | Model-based estimation of the economic burden of cholera in Africa. | BMJ Open | 03/2022 |
1342 | Chatterjee S, Song D, Das P, Haldar P, Ray A, Brenzel L, Boonstoppel L, Mogasale V | Cost of conducting Measles-Rubella vaccination campaign in India. | Hum Vaccin Immunother | 03/2022 |
1341 | Lee P, Kim CU, Seo SH, Kim DJ | Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages. | Immune Netw | 03/2022 |
No.1355 | Author | Jiamsiri S, Rhee C, Ahn HS, Poudyal N, Seo HW, Klinsupa W, Nilyanimit P, Premsri N, Namwat C, Vonpunsawad S, Chon Y, Park S, Kim DR, Unger ER, Markowitz L, Poovorawan Y, Rerks-Ngarm S, Excler JL, Lynch J |
Title | A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX(R)) in female school students in Thailand. | |
Journal Name | PLoS One | |
Month / Year | 05/2022 | |
No.1354 | Author | Kim JH |
Title | Managing Safe, Equitable, and Effective COVID-19 Vaccination. | |
Journal Name | Development Asia | |
Month / Year | 03/2022 | |
No.1353 | Author | Lewitus E, Sanders-Buell E, Bose M, O'Sullivan AM, Poltavee K, Li Y, Bai H, Mdluli T, Donofrio G, Slike B, Zhao H, Wong K, Chen L, Miller S, Lee J, Ahani B, Lepore S, Muhammad S, Grande R, Tran U, Dussupt V, Mendez-Rivera L, Nitayaphan S, Kaewkungwal J, Pitisuttithum P, Rerks-Ngarm S, O'Connell RJ, Janes H, Gilbert PB, Gramzinski R, Vasan S, Robb ML, Michael NL, Krebs SJ, Herbeck JT, Edlefsen PT, Mullins JI, Kim JH, Tovanabutra S, Rolland M |
Title | RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection. | |
Journal Name | Virus Evol | |
Month / Year | 03/2022 | |
No.1352 | Author | Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members |
Title | Operation Warp Speed: implications for global vaccine security. | |
Journal Name | Lancet Glob Health | |
Month / Year | 03/2022 | |
No.1351 | Author | Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members |
Title | Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics. | |
Journal Name | Lancet | |
Month / Year | 03/2022 | |
No.1350 | Author | Panzner U, Excler JL, Kim JH, Marks F, Carter D, Siddiqui AA |
Title | Recent Advances and Methodological Considerations on Vaccine Candidates for Human Schistosomiasis. | |
Journal Name | Front Trop Dis | |
Month / Year | 03/2022 | |
No.1349 | Author | Kim JH, McCann C |
Title | The emergence of a South-South and Triangular Cooperation approach to vaccine development. | |
Journal Name | J Glob Health Sci | |
Month / Year | 03/2022 | |
No.1348 | Author | Park SM, Gu MJ, Ju YJ, Cheon IS, Hwang KJ, Gill B, Shim BS, Jeong HJ, Son YM, Choi S, Jeung W, Han SH, Chu H, Yun CH |
Title | Intranasal Vaccination with Outer-Membrane Protein of Orientia tsutsugamushi induces Protective Immunity Against Scrub Typhus. | |
Journal Name | Immune Netw | |
Month / Year | 03/2022 | |
No.1347 | Author | Ali M, Qadri F, Kim DR, Islam MT, Im J, Ahmmed F, Khan AI, Zaman K, Marks F, Kim JH, Clemens JD |
Title | Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial. | |
Journal Name | Lancet Infect Dis | |
Month / Year | 03/2022 | |
No.1346 | Author | Alexander N, Carabali M, Lim JK |
Title | Estimating force of infection from serologic surveys with imperfect tests. | |
Journal Name | PLoS One | |
Month / Year | 03/2022 | |
No.1345 | Author | Fu H, Abbas K, Klepac P, van Zandvoort K, Tanvir H, Portnoy A, Jit M |
Title | Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries. | |
Journal Name | BMC Med | |
Month / Year | 03/2022 | |
No.1344 | Author | Mogasale VV, Saldanha P, Pai V, Rekha PD, Mogasale V |
Title | A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India. | |
Journal Name | Sci Rep | |
Month / Year | 03/2022 | |
No.1343 | Author | Mogasale V, Ngogoyo SM, Mogasale VV |
Title | Model-based estimation of the economic burden of cholera in Africa. | |
Journal Name | BMJ Open | |
Month / Year | 03/2022 | |
No.1342 | Author | Chatterjee S, Song D, Das P, Haldar P, Ray A, Brenzel L, Boonstoppel L, Mogasale V |
Title | Cost of conducting Measles-Rubella vaccination campaign in India. | |
Journal Name | Hum Vaccin Immunother | |
Month / Year | 03/2022 | |
No.1341 | Author | Lee P, Kim CU, Seo SH, Kim DJ |
Title | Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages. | |
Journal Name | Immune Netw | |
Month / Year | 03/2022 |